Table 3.
Variables | Hazard ratio | 95% Confidence interval | p value |
---|---|---|---|
Overall survival | |||
PTEN Positive (scores 1, 2, 3) | |||
Negative (score 0) | 2.47 | 1.97–3.10 | <0.0001 |
Gleason score (score ≤6) | |||
4 + 3 | 3.21 | 2.21–4.66 | <0.0001 |
3 + 4 | 1.81 | 1.24–2.64 | 0.002 |
8 | 5.07 | 3.44–7.47 | <0.0001 |
9–10 | 5.62 | 4.39–7.47 | <0.0001 |
SRPK1 (score 0, 1, 2) | |||
Score 3 | 1.99 | 1.57–2.54 | <0.0001 |
Prostate cancer–specific survival | |||
PTEN positive (scores 1, 2, 3) | |||
Negative (score 0) | 2.01 | 1.47–2.74 | <0.0001 |
Gleason score (score ≤6) | |||
4 + 3 | 14.36 | 4.75–43.40 | <0.0001 |
3 + 4 | 8.04 | 2.59–24.96 | <0.0001 |
8 | 28.67 | 9.77–84.11 | <0.0001 |
9–10 | 39.79 | 14.65–108.09 | <0.0001 |
SRPK1 (scores 0, 1, 2) | |||
Score 3 | 1.64 | 1.19–2.26 | 0.002 |
SRPK1 = serine-arginine protein kinase 1; TURP = transurethral resection of the prostate.
SRPK1 scores: 0, negative; 1, weak; 2, moderate; and 3, high.